About
Generics, Small Molecule
Areas of Focus
Categories
Small Molecule PharmaceuticalGeneric DrugPoland
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
950
By Phase
PHASE2: 6PHASE1: 5
By Status
COMPLETED: 9UNKNOWN: 1RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05374785Lead Sponsor
Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis
PHASE2Completed
106 participants
Started: May 1, 2022 · Completed: May 27, 2024
NCT05248776Lead Sponsor
Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes
PHASE2Unknown
80 participants
Started: Jan 21, 2022 · Completed: Jun 30, 2023
NCT05297201Lead Sponsor
Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia
PHASE2Completed
105 participants
Started: Nov 2, 2021 · Completed: Jan 27, 2025
NCT05278156Lead Sponsor
Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia
PHASE2Completed
189 participants
Started: May 19, 2021 · Completed: Jun 19, 2024
NCT04670757Lead Sponsor
Safety and Pharmacokinetics of JAK/ROCK Inhibitor in Healthy Volunteers
PHASE1Completed
65 participants
Started: Dec 8, 2020 · Completed: Sep 8, 2021
Locations (1)
Headquarters
Kielpin, Poland
Map
Loading map...